69 related articles for article (PubMed ID: 184555)
1. Treatment of cerebral vasospasm by control of cyclic adenosine monophosphate.
Flamm ES; Ransohoff J
Surg Neurol; 1976 Oct; 6(4):223-6. PubMed ID: 184555
[TBL] [Abstract][Full Text] [Related]
2. Aminophylline and isoproterenol in the treatment of cerebral vasopasm.
Fleischer AS; Raggio JF; Tindall GT
Surg Neurol; 1977 Aug; 8(2):117-21. PubMed ID: 888087
[TBL] [Abstract][Full Text] [Related]
3. Experimental cerebral vasospasm and cyclic adenosine monophosphate (c-AMP).
Kim J; Flamm ES; Lin J
Invest Radiol; 1975; 10(3):239-43. PubMed ID: 166052
[TBL] [Abstract][Full Text] [Related]
4. Phosphodiesterase inhibitors and cerebral vasospasm.
Flamm ES; Kim J; Lin J; Ransohoff J
Arch Neurol; 1975 Aug; 32(8):569-71. PubMed ID: 168844
[TBL] [Abstract][Full Text] [Related]
5. Physiological considerations important for the management of vasospasm.
Sundt TM; Szurszewski J; Sharbrough FW
Surg Neurol; 1977 May; 7(5):259-67. PubMed ID: 324008
[TBL] [Abstract][Full Text] [Related]
6. Experimental alterations in cyclic adenosine monophosphate concentrations in the cat basilar artery.
Flamm ES; Viau A; Ransohoff J; Naftchi NE
Neurology; 1976 Jul; 26(7):664-6. PubMed ID: 180456
[TBL] [Abstract][Full Text] [Related]
7. Cerebral vasospasm following aneurysm rupture. A protocol for therapy and prophylaxis.
Fleischer AS; Tindall GT
J Neurosurg; 1980 Feb; 52(2):149-52. PubMed ID: 7351553
[TBL] [Abstract][Full Text] [Related]
8. Impairment in biochemical level of arterial dilative capability of a cyclic nucleotides-dependent pathway by induced vasospasm in the canine basilar artery.
Todo H; Ohta S; Wang J; Ichikawa H; Ohue S; Kumon Y; Sakaki S
J Cereb Blood Flow Metab; 1998 Jul; 18(7):808-17. PubMed ID: 9663510
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of medical treatment (isoproterenol + aminophylline) of aneurysm rupture spasm].
George B; Muzard O; Begue T; Roux FX; Goldstein A; Ragueneau JL
Neurochirurgie; 1984; 30(4):273-6. PubMed ID: 6472552
[TBL] [Abstract][Full Text] [Related]
10. A review of recent advances in vascular smooth muscle pharmacology.
Norwood CW
Surg Neurol; 1977 Feb; 7(2):91-4. PubMed ID: 13504
[TBL] [Abstract][Full Text] [Related]
11. A theory of the mechanism of cerebral vasospasm and its reversal, the role of calcium and cyclic AMP.
Peterson EW; Leblanc R
Can J Neurol Sci; 1976 Nov; 3(4):223-6. PubMed ID: 187308
[TBL] [Abstract][Full Text] [Related]
12. [Intravenous nimodipine in the treatment of cerebral vasospasm following subarachnoid hemorrhage caused by aneurysm rupture: a comparative multicenter study].
Desbordes JM; Ades PE; Guggiari M
Agressologie; 1989 Jun; 30(7):438-40. PubMed ID: 2683824
[TBL] [Abstract][Full Text] [Related]
13. Delayed cerebral vasospasm is not reversible by aminophylline, nifedipine, or papaverine in a "two-hemorrhage" canine model.
Varsos VG; Liszczak TM; Han DH; Kistler JP; Vielma J; Black PM; Heros RC; Zervas NT
J Neurosurg; 1983 Jan; 58(1):11-7. PubMed ID: 6847896
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cerebral vasospasm from subarachnoid hemorrhage with isoproterenol and lidocaine hydrochloride.
Sundt TM; Onofrio BM; Merideth J
J Neurosurg; 1973 May; 38(5):557-60. PubMed ID: 4711626
[No Abstract] [Full Text] [Related]
15. [Clinical effect of nitroglycerin (GTN) on prevention of cerebral vasospasm].
Sasanuma J; Goto T; Ogayama H; Sasaki J; Watanabe K
No Shinkei Geka; 1991 Mar; 19(3):227-32. PubMed ID: 1903850
[TBL] [Abstract][Full Text] [Related]
16. Effect of aminophylline and isoproterenol on spinal cord blood flow after impact injury.
Dow-Edwards D; DeCrescito V; Tomasula JJ; Flamm ES
J Neurosurg; 1980 Sep; 53(3):385-90. PubMed ID: 6252296
[TBL] [Abstract][Full Text] [Related]
17. Ther reversal of experimental vasospasm by dibutyryl-3',5'-adenosine monophosphate.
Peterson EW; Searle R; Mandy FF; Leblanc R
J Neurosurg; 1973 Dec; 39(6):730-4. PubMed ID: 4357243
[No Abstract] [Full Text] [Related]
18. Use of nimodipine for prevention and treatment of cerebral arterial spasm in patients with subarachnoid hemorrhage.
Welty TE
Clin Pharm; 1987 Dec; 6(12):940-6. PubMed ID: 3322639
[TBL] [Abstract][Full Text] [Related]
19. Aminophylline plus nitroprusside and dopamine for treatment of cerebral vasospasm. A preliminary report.
Levy WJ; Bay JW; Sawhny B; Tank T
J Neurosurg; 1982 May; 56(5):646-9. PubMed ID: 7069476
[No Abstract] [Full Text] [Related]
20. Identification, characterization, and functional role of phosphodiesterase type IV in cerebral vessels: effects of selective phosphodiesterase inhibitors.
Willette RN; Shiloh AO; Sauermelch CF; Sulpizio A; Michell MP; Cieslinski LB; Torphy TJ; Ohlstein EH
J Cereb Blood Flow Metab; 1997 Feb; 17(2):210-9. PubMed ID: 9040501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
